Targeting a specific vulnerability in a rare type of small cell lung cancer
Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer
This study is looking at a special type of small cell lung cancer that has some unique features, and it's trying to find new treatments by focusing on a protein called POU2F3 that these cancer cells really rely on, so that we can help patients with this tough disease feel better.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cold Spring Harbor Laboratory NIH-funded |
| Lab location | 1 site (Cold Spring Harbor, United States) |
| Project ID | NIH-10693821 on NIH RePORTER |
What this research studies
This research focuses on a novel variant of small cell lung cancer (SCLC) that resembles tuft cells, which are a specific type of cell in the body. The researchers have identified unique molecular vulnerabilities in this variant, particularly an addiction to a protein called POU2F3. By understanding how POU2F3 functions in these tumors, the team aims to develop targeted therapies that can disrupt this dependency, potentially leading to more effective treatments for patients with this aggressive cancer. The approach involves advanced genomic techniques to identify critical binding sites of POU2F3 in the cancer cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with the tuft cell variant of small cell lung cancer.
Not a fit: Patients with other forms of lung cancer or those without the tuft cell variant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, targeted therapies that improve outcomes for patients with tuft cell variant small cell lung cancer.
How similar studies have performed: While targeting specific molecular vulnerabilities in cancer is a growing field, this particular approach focusing on POU2F3 in tuft cell variant SCLC is novel and has not been extensively tested.
Where this research is happening
Cold Spring Harbor, United States
- Cold Spring Harbor Laboratory — Cold Spring Harbor, United States (Active)
Researchers
- Principal investigator: Vakoc, Christopher — Cold Spring Harbor Laboratory
- Study coordinator: Vakoc, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.